PL3175840T3 - Kompozycje wypełniacza skórnego - Google Patents

Kompozycje wypełniacza skórnego

Info

Publication number
PL3175840T3
PL3175840T3 PL16205773T PL16205773T PL3175840T3 PL 3175840 T3 PL3175840 T3 PL 3175840T3 PL 16205773 T PL16205773 T PL 16205773T PL 16205773 T PL16205773 T PL 16205773T PL 3175840 T3 PL3175840 T3 PL 3175840T3
Authority
PL
Poland
Prior art keywords
dermal filler
filler compositions
compositions
dermal
filler
Prior art date
Application number
PL16205773T
Other languages
English (en)
Inventor
Gabriel N. NJIKANG
Xiaojie Yu
Futian Liu
Nicholas J. Manesis
Original Assignee
Allergan Industrie, Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/486,754 external-priority patent/US9149422B2/en
Priority claimed from US13/593,313 external-priority patent/US9393263B2/en
Priority claimed from US13/615,193 external-priority patent/US9408797B2/en
Application filed by Allergan Industrie, Sas filed Critical Allergan Industrie, Sas
Publication of PL3175840T3 publication Critical patent/PL3175840T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/17—Amines; Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
PL16205773T 2011-12-08 2012-12-05 Kompozycje wypełniacza skórnego PL3175840T3 (pl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161568618P 2011-12-08 2011-12-08
US13/486,754 US9149422B2 (en) 2011-06-03 2012-06-01 Dermal filler compositions including antioxidants
US13/593,313 US9393263B2 (en) 2011-06-03 2012-08-23 Dermal filler compositions including antioxidants
US13/615,193 US9408797B2 (en) 2011-06-03 2012-09-13 Dermal filler compositions for fine line treatment
EP12799706.2A EP2787959B1 (en) 2011-12-08 2012-12-05 Dermal filler compositions
EP16205773.1A EP3175840B1 (en) 2011-12-08 2012-12-05 Dermal filler compositions
PCT/US2012/067993 WO2013086024A2 (en) 2011-12-08 2012-12-05 Dermal filler compositions

Publications (1)

Publication Number Publication Date
PL3175840T3 true PL3175840T3 (pl) 2021-01-25

Family

ID=48575052

Family Applications (2)

Application Number Title Priority Date Filing Date
PL16205773T PL3175840T3 (pl) 2011-12-08 2012-12-05 Kompozycje wypełniacza skórnego
PL12799706T PL2787959T3 (pl) 2011-12-08 2012-12-05 Kompozycje wypełniacza skórnego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12799706T PL2787959T3 (pl) 2011-12-08 2012-12-05 Kompozycje wypełniacza skórnego

Country Status (10)

Country Link
EP (3) EP3175840B1 (pl)
KR (4) KR102168028B1 (pl)
AU (5) AU2012347935B2 (pl)
CA (1) CA2858366C (pl)
DK (2) DK2787959T3 (pl)
ES (2) ES2824232T3 (pl)
HU (2) HUE050947T2 (pl)
PL (2) PL3175840T3 (pl)
RU (2) RU2679317C1 (pl)
WO (1) WO2013086024A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
EP2714002B1 (en) 2011-06-03 2019-04-03 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
WO2016201382A1 (en) * 2015-06-11 2016-12-15 The Regents Of The University Of California Novel hyaluronic acid-based hydrogels having medical applications
EP3623390B1 (en) 2015-12-29 2023-08-02 Galderma S.A. Carbohydrate crosslinker
MA52877A (fr) 2018-06-15 2021-04-21 Croma Pharma Ges M B H Acide hyaluronique stabilisé
CN109503864B (zh) * 2018-12-04 2021-06-29 上海其胜生物制剂有限公司 一类具有内聚增强特性的可注射水凝胶的制备方法
LU101045B1 (en) * 2018-12-11 2020-06-11 Qventis GmbH Method for the manufacture and use of a bionic hydrogel composition for medical applications
WO2021000050A1 (en) * 2019-07-03 2021-01-07 Molly Sandra Shoichet Hydrogel compositions and uses thereof
KR20220110786A (ko) 2019-12-02 2022-08-09 갈더마 홀딩 소시에떼 아노님 고분자량 에스테틱 조성물
US20230040919A1 (en) * 2019-12-26 2023-02-09 Allergan, Inc. Crosslinked ha-collagen hydrogels as dermal fillers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IT1317091B1 (it) * 2000-02-08 2003-05-26 S F I R Societa Fondaria Ind R Gel di acido ialuronico cross-linked con l-amminoacidi ol-amminoesteri bifunzionali.
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
WO2004073759A1 (en) 2003-02-19 2004-09-02 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20050226936A1 (en) * 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
FR2873379B1 (fr) * 2004-07-23 2008-05-16 Jerome Asius Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation
FR2878444B1 (fr) 2004-11-30 2008-04-25 Corneal Ind Soc Par Actions Si Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
GB0816496D0 (en) * 2008-09-10 2008-10-15 Zhao Xiaobin Hyaluronic acid cryogel
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
KR20200116168A (ko) * 2011-09-14 2020-10-08 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물

Also Published As

Publication number Publication date
AU2021221920A1 (en) 2021-09-23
KR102168028B1 (ko) 2020-10-20
EP3175840A1 (en) 2017-06-07
RU2638713C2 (ru) 2017-12-15
AU2017276280A1 (en) 2018-01-18
WO2013086024A3 (en) 2014-07-17
AU2021221920B2 (en) 2023-10-19
KR20190102089A (ko) 2019-09-02
AU2019216643A1 (en) 2019-09-05
HUE050978T2 (hu) 2021-01-28
KR102265076B1 (ko) 2021-06-14
KR20200121382A (ko) 2020-10-23
WO2013086024A2 (en) 2013-06-13
AU2024200249A1 (en) 2024-02-01
EP3175840B1 (en) 2020-06-24
AU2019216643B2 (en) 2021-05-27
ES2824232T3 (es) 2021-05-11
DK2787959T3 (da) 2020-09-21
PL2787959T3 (pl) 2021-01-25
ES2823650T3 (es) 2021-05-07
CA2858366C (en) 2020-01-21
AU2012347935A1 (en) 2014-07-03
AU2017276280B2 (en) 2019-05-30
DK3175840T3 (da) 2020-09-28
RU2014127607A (ru) 2016-02-10
RU2679317C1 (ru) 2019-02-07
KR20140108260A (ko) 2014-09-05
KR102052775B1 (ko) 2019-12-04
KR20210071106A (ko) 2021-06-15
EP3721865A1 (en) 2020-10-14
HUE050947T2 (hu) 2021-01-28
EP2787959A2 (en) 2014-10-15
EP2787959B1 (en) 2020-06-24
AU2012347935B2 (en) 2017-10-19
CA2858366A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
PL2787959T3 (pl) Kompozycje wypełniacza skórnego
HK1203403A1 (en) Peracid-generating compositions
ZA201308399B (en) Improved composition
GB201220354D0 (en) Dermal compositions
GB201117619D0 (en) Compositions
SG11201401335QA (en) Compositions
GB201117621D0 (en) Compositions
HK1163562A1 (en) Dermal filler composition
EP2730619A4 (en) COMPOSITION
EP2763756A4 (en) BROMOFLUOROCARBON COMPOSITIONS
HK1198425A1 (en) Dermal filler compositions including antioxidants
EP2692796A4 (en) COMPOSITION
GB2496447B (en) Compositions
GB201110833D0 (en) Compositions
GB201103942D0 (en) Compositions
HK1201687A1 (en) Improved compositions
GB201110132D0 (en) compositions
GB201104849D0 (en) Compositions
ZA201309110B (en) Composition
GB201122213D0 (en) Compositions
GB201122216D0 (en) Compositions
GB201122214D0 (en) Compositions
GB201121028D0 (en) Compositions
GB201120406D0 (en) Compositions
GB201117234D0 (en) Compositions